Faculty

Institution

Unit

Venue

Bradley Broom

The University of Texas MD Anderson Cancer Center

Affiliations

Metabolomics Core Facility

Department Of Bioinformatics And Computational Biology

The University of Texas MD Anderson Cancer Center

NoneBradley Broom is currently serving as a Bioinformatics And Computational Biology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Bradley Broom

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

cancer research oncology cancer biology cell biology molecular biology tumor biology cancer genomics molecular cancer urology prostate cancer cancer cells genetics oncogenes bioinformatics medicinal research cancer genetics colorectal cancer genomics cancer care cancer treatment cancer discovery genome biology molecular diagnostics tumor targeting cell signaling genitourinary cancers breast cancer prostatic disease cancer imaging cellular therapy signaling pathways cancer genome atlas surgical oncology molecular cell biology pathway analysis leukemia enzyme inhibition tumor suppressors gastrointestinal oncology anti-cancer agents breast oncology molecular characterization cancer management interactive data exploration comprehensive molecular characterization castration-resistant prostate cancer cell research pharmacotherapy hematological malignancies cancer growth rna biology endocrine-related cancers computational genomics consensus molecular subtypes metastatic colorectal cancer cancer risk genome analysis protein bioinformatics cellular biology epigenomics cell regulation treatment development clinical gastroenterology microarray data analysis apoptosis human cancers pan-cancer proteomic perspective cancer types pan-cancer analysis androgen receptor molecular taxonomy primary prostate cancer urothelial bladder carcinoma cell-of-origin patterns molecular classification muscle-invasive bladder cancer

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1061: Prostate Cancer Cartography Initiative (Pcci): Integrating Genetic and Clinical Data to Explore Prostate Cancer Biomarkers. Cancer Research (2025)

urologyhuman geneticsintegrating geneticprostate cancer biomarkersbiostatisticsgenitourinary cancersclinical databiomarkerscancer genomicscancer discoverymolecular diagnosticsprostate cancerbiomedical informatics

Abstract 3123: Fracturing the Tumor-Bone Alliance in Metastatic Prostate Cancer With Ra-223. Cancer Research (2025)

Pablo SanchisAgustina SabaterJuan BizzottoGaston PascualNicolas AnselminoJiabin DongJun YangGaniraju ManyamBradley BroomZhongcheng ShiShixia HuangRocio SeniukEleonora DondossolaTeocharis PanaretakisJohn AraujoPeter ShepherdPatricia TroncosoNora NavoneChristopher J. LogothetisDaniel E. FrigoElba VazquezPaul CornGeraldine GueronEstefania Labanca

cancer biologycancer researchmetastatic prostate cancertumor-bone allianceprostate cancer

Supplementary Table S9 From Spop Mutations Target Sting1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to Parp Inhibitor–Induced Growth Suppression. (2025)

cancer biologymolecular cell biologymolecular cancercancer cellscreate therapeutic vulnerabilitiesoncogenesprostate cancersupplementary table s9molecular biologycancer geneticscell signalingtumor biologysignaling pathwayscell biologytherapeutic targets

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

Andrew W. HahnGaniraju C. ManyamBrian F. ChapinMiao ZhangYao YuCurtis A. PettawayLisly CheryLouis L. PistersJohn F. WardJustin R. GreggJohn PapadopoulosAshish M. KamatMarisa LozanoAnh HoangBradley BroomXuemei WangChad D. HuffChristopher J. LogothetisPatricia TroncosoPatrick G. PiliéJohn W. Davis

pharmacologyurologyneurologyclinical trialsoncologyphase ii trialintermediate-risk prostate cancermolecular correlatesprostate cancer

Figure S2 From Atr Inhibition Induces Cdk1–Spop Signaling and Enhances Anti–Pd-L1 Cytotoxicity in Prostate Cancer. (2024)

pharmacologyurologymolecular cancercancer biologycancer cellsfigure s2enhances anti–pd-l1 cytotoxicitycancer researchtherapeutic targetsprostatic diseasecell signalingcell biologyprostate cancer

Funcpep V2.0: An Updated Database of Functional Short Peptides Translated From Non-Coding Rnas. Non-Coding RNA (2024)

functional genomicsbioinformaticsrna biologynon-coding rnasmolecular informaticsbiochemistrynucleic acidsmolecular biologypeptidestranscriptomefuncpep v2.0protein synthesis

Pca-Plus: Enhanced Principal Component Analysis With Illustrative Applications to Batch Effects and Their Quantitation. bioRxiv (Cold Spring Harbor Laboratory) (2024)

statisticspattern recognitionprincipal component analysisdimensionality reductiondata scienceillustrative applicationslinear algebraindependent component analysis

RETRACTED: Liu Et Al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. Cancers 2023, 15, 4044. Cancers (2024)

histopathology imagespathologydeep learningcancer imagingdeep learning analysisbiomedical data analysisoncologymedical image computingbiomedical data scienceovarian cancerdigital pathologyovarian cancer responsegynecologic oncologygynecologybiomedical informatics

Single-Cell Chromatin Accessibility Reveals Malignant Regulatory Programs in Primary Human Cancers. Science (2024)

Laksshman SundaramArvind KumarMatthew ZatzmanAdriana SalcedoNeal RavindraShadi ShamsBrian H. LouieS. Tansu BagdatliMatthew A. MyersShahab SarmashghiHyo Young ChoiWon-Young ChoiKathryn E. YostYanding ZhaoJeffrey M. GranjaToshinori HinoueD. Neil HayesAndrew CherniackIna FelauHani ChoudhryJean C. ZenklusenKyle Kai-How FarhAndrew McPhersonChristina CurtisPeter W. LairdM. Ryan CorcesHoward Y. ChangWilliam J. GreenleafJohn A. DemchokLiming YangRoy TarnuzzerSamantha J. Caesar-JohnsonZhining WangAshley S. DoaneEkta KhuranaMauro A. A. CastroAlexander J. LazarBradley M. BroomJohn N. WeinsteinRehan AkbaniShwetha V. KumarBenjamin J. RaphaelChristopher K. WongJoshua M. StuartRojin SafaviChristopher C. BenzBenjamin K. JohnsonCindy KyiHui Shen

single-cell analysissingle cell sequencingcancer cellscell biologychromatincancer biologymolecular cancercancer researchtumor heterogeneitycancer genomicstumor biologycarcinogenesisprimary human cancersmolecular cell biologyoncogenestumor microenvironmentcancer discoverymolecular biologysystems biology

Supplementary Figure S1 From a Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data. (2024)

molecular profiling datamolecular graphicssupplementary figure s1interactive explorationbioinformaticsscientific dataastronomymolecular informaticsbiological network visualizationgalaxy clustersplanetary sciencesscientific visualizationbiomedical informatics

1
2
3
4
5
14
10 / page

Bradley Broom

The University of Texas MD Anderson Cancer Center

Affiliations

Metabolomics Core Facility

Department Of Bioinformatics And Computational Biology

The University of Texas MD Anderson Cancer Center

NoneBradley Broom is currently serving as a Bioinformatics And Computational Biology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Bradley Broom

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1061: Prostate Cancer Cartography Initiative (Pcci): Integrating Genetic and Clinical Data to Explore Prostate Cancer Biomarkers. Cancer Research (2025)

Abstract 3123: Fracturing the Tumor-Bone Alliance in Metastatic Prostate Cancer With Ra-223. Cancer Research (2025)

cancer biologycancer researchmetastatic prostate cancertumor-bone allianceprostate cancer

Supplementary Table S9 From Spop Mutations Target Sting1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to Parp Inhibitor–Induced Growth Suppression. (2025)

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

pharmacologyurologyneurologyclinical trialsoncologyphase ii trialintermediate-risk prostate cancermolecular correlatesprostate cancer

Figure S2 From Atr Inhibition Induces Cdk1–Spop Signaling and Enhances Anti–Pd-L1 Cytotoxicity in Prostate Cancer. (2024)

pharmacologyurologymolecular cancercancer biologycancer cellsfigure s2enhances anti–pd-l1 cytotoxicitycancer researchtherapeutic targetsprostatic diseasecell signalingcell biologyprostate cancer

Funcpep V2.0: An Updated Database of Functional Short Peptides Translated From Non-Coding Rnas. Non-Coding RNA (2024)

functional genomicsbioinformaticsrna biologynon-coding rnasmolecular informaticsbiochemistrynucleic acidsmolecular biologypeptidestranscriptomefuncpep v2.0protein synthesis

Pca-Plus: Enhanced Principal Component Analysis With Illustrative Applications to Batch Effects and Their Quantitation. bioRxiv (Cold Spring Harbor Laboratory) (2024)

statisticspattern recognitionprincipal component analysisdimensionality reductiondata scienceillustrative applicationslinear algebraindependent component analysis

RETRACTED: Liu Et Al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. Cancers 2023, 15, 4044. Cancers (2024)

Single-Cell Chromatin Accessibility Reveals Malignant Regulatory Programs in Primary Human Cancers. Science (2024)

Supplementary Figure S1 From a Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data. (2024)

1
2
3
4
5
14
10 / page